DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C1306459 | Primary malignant neoplasm | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0026764 | Multiple Myeloma | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0007102 | Malignant tumor of colon | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0024623 | Malignant neoplasm of stomach | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0025202 | melanoma | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0678222 | Breast Carcinoma | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0878500 | Intraepithelial Neoplasia | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0026618 | Dental Fluorosis, Acquired | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0026769 | Multiple Sclerosis | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0699791 | Stomach Carcinoma | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0334579 | Anaplastic astrocytoma | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0031106 | Aggressive Periodontitis | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0006118 | Brain Neoplasms | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0017636 | Glioblastoma | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0699790 | Colon Carcinoma | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0003873 | Rheumatoid Arthritis | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0221356 | Brachycephaly | ALG13 | 79868 | ALG13 UDP-N-acetylglucosaminyltransferase subunit | Q9NP73 |
C0086237 | Epilepsy, Cryptogenic | ALG13 | 79868 | ALG13 UDP-N-acetylglucosaminyltransferase subunit | Q9NP73 |
C3550904 | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36 | ALG13 | 79868 | ALG13 UDP-N-acetylglucosaminyltransferase subunit | Q9NP73 |
C0036857 | Severe intellectual disability | ALG13 | 79868 | ALG13 UDP-N-acetylglucosaminyltransferase subunit | Q9NP73 |
C0029124 | Optic Atrophy | ALG13 | 79868 | ALG13 UDP-N-acetylglucosaminyltransferase subunit | Q9NP73 |
C3714756 | Intellectual Disability | ALG13 | 79868 | ALG13 UDP-N-acetylglucosaminyltransferase subunit | Q9NP73 |
C0017668 | Focal glomerulosclerosis | ALG13 | 79868 | ALG13 UDP-N-acetylglucosaminyltransferase subunit | Q9NP73 |
C0014544 | Epilepsy | ALG13 | 79868 | ALG13 UDP-N-acetylglucosaminyltransferase subunit | Q9NP73 |
C1263846 | Attention deficit hyperactivity disorder | ALG13 | 79868 | ALG13 UDP-N-acetylglucosaminyltransferase subunit | Q9NP73 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024